Association between hyperuricemia and coronary artery disease severity among patients undergoing coronary angiography
Keywords:
hyperuricemia, coronary artery disease (CAD), severity, associationAbstract
Aim: To determine the association between hyperuricemia and coronary artery disease severity among patients undergoing coronary angiography. Methods: This study was conducted at multi centers including Al- Aleem Medical College (Gulab Devi Teaching Hospital) Lahore and Fatima Memorial Hospital Lahore in the duration from December, 2022 to May, 2023. Total 180 patients were presented with Coronary Artery Disease, Coronary angiography was performed to determine the presence of coronary artery disease, with patients having luminal stenosis of greater than 50% in at least one of the coronary arteries. Relation between hyperuricemia and coronary artery disease was assessed using Chi Square test keeping P < 0.05 as significant. Results: The mean age was 49.59±6.11 years. The frequency of hyperuricemia was 120 (66.7%), around 32.3% patients had mild CAD, about 37.2% patients had moderate CAD while 30.6% patients had severe CAD. We found a significant association between hyperuricemia and severity of CAD. Conclusion: We conclude that hyperuricemia is significantly associated with the severity of coronary artery disease (CAD).
Downloads
References
Zhang S, Wang Y, Cheng J, Huangfu N, Zhao R, Xu Z, et al. Hyperuricemia and cardiovascular disease. Curr Pharm Des. 2019;25(6):700-9.
Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta‐analysis. Arthritis Care & Research: J Am Coll Rheumatol. 2010;62(2):170-80.
Wu J, Lei G, Wang X, Tang Y, Cheng H, Jian G, et al. Asymptomatic hyperuricemia and coronary artery disease in elderly patients without comorbidities. Oncotarget. 2017;8(46):80688.
Zuo T, Liu X, Jiang L, Mao S, Yin X, Guo L. Hyperuricemia and coronary heart disease mortality: a meta-analysis of prospective cohort studies. BMC Cardiovasc Disorder. 2016;16(1):1-0.
Palazzuoli A, Hashemi H, Jameson LC, McCullough PA. Hyperuricemia and Cardiovascular Disease. Rev Cardiovasc. 2017;18(4):134-45.
Borghi C, Palazzuoli A, Landolfo M, Cosentino E. Hyperuricemia: a novel old disorder relationship and potential mechanisms in heart failure. Heart Fail Rev. 2020;25:43-51.
Chazova IE, Zhernakova JV, Kisliak OA, Nedogoda SV, Podzolkov VI, Oshchepkova EV, et al. Consensus on patients with hyperuricemia and high cardiovascular risk treatment. Systemic Hypertension. 2019;16(4):8-21.
Shahin L, Patel KM, Heydari MK, Kesselman MM, Heydari-Kamjani M. Hyperuricemia and cardiovascular risk. Cureus. 2021;13(5):e14855
Li M, Hu X, Fan Y, Li K, Zhang X, Hou W, et al. Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis. Sci Rep. 2016;6(1):1-11.
Chiang KM, Tsay YC, Vincent Ng TC, Yang HC, Huang YT, Chen CH, et al. Is hyperuricemia, an early-onset metabolic disorder, causally associated with cardiovascular disease events in han Chinese?. J Clin Med. 2019;8(8):1-19.
Kuwabra M. Hyperuricemia, cardiovascular disease and hypertension. Pulse. 2015;3(1)242-52.
Gagliardi AC, Miname MS, Santos MD. Uric acid: A marker of increased cardiovascular risk. Atherosclerosis. 2009;202(1):11-7.
Larsen TR, Gerke O, Diederichsen AC, Lambrechtsen J, Steffensen FH, Sand NP, et al. The association between uric acid levels and different clinical manifestations of coronary artery disease. Coron Artery Dis. 2018;29(3):194-203.
Akhtar A, Zaffar MZ, Minhas R, Saeed HY, Niazi GZK. Association of Hyperuricemia with the Presence and Severity of Coronary Artery Disease in Patients Undergoing Coronary Angiography. Pak Heart J. 2021;54(02):157-161.
Goodarzynejad H, Anvari MS, Boroumand MA, Karimi A, Abbasi SH, Davoodi G. Hyperuricemia and the presence and severity of coronary artery disease. Lab Med. 2010;41:40–45.
Alderman M, Aiyer KJ. Uric acid: role in cardiovascular disease and effects of losartan. Curr Med Res Opin. 2004;20:369–379.
Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999;131:7–13.
Lv S, Liu W, Zhou Y, et al. Hyperuricemia and severity of coronary artery disease: an observational study in adults 35 years of age and younger with acute coronary syndrome. Cardiol J. 2019;26:275–282.
Zhang C, Jiang L, Xu L, et al. Implications of hyperuricemia in severe coronary artery disease Am J Cardiol. 2019;123:558–564.
Krishnan E, Pandya BJ, Lingala B, Hariri A, Dabbous O. Hyperuricemia and untreated gout are poor prognostic markers among those with a recent acute myocardial infarction. Arthritis Res Ther. 2012;14:0.
Casiglia E, Tikhonoff V, Virdis A, et al. Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: the URRAH (Uric Acid Right for Heart Health) study. J Hypertens. 2020;38:412–419.
Tardif JC, Kouz S, Waters DD, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381:2497–2505.
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
